While a distinct minicolumnar phenotype seems to be an underlying factor in a significant portion of cases of autism, great attention is being paid not only to genetics but to epigenetic factors which may lead to development of the conditions. Here we discuss the indivisible role the molecular environment plays in cellular function, particularly the pivotal position which the transcription factor and adhesion molecule, β-catenin, occupies in cellular growth. In addition, the learning environment is not only integral to postnatal plasticity, but the prenatal environment plays a vital role during corticogenesis, neuritogenesis, and synaptogenesis as well. To illustrate these points in the case of autism, we review important findings in genetics studies (e.g., PTEN, TSC1/2, FMRP, MeCP2, Neurexin-Neuroligin) and known epigenetic factors (e.g., valproic acid, estrogen, immune system, ultrasound) which may predispose towards the minicolumnar and connectivity patterns seen in the conditions, showing how one-gene mutational syndromes and exposure to certain CNS teratogens may ultimately lead to comparable phenotypes. This in turn may shed greater light on how environment and complex genetics combinatorially give rise to a heterogenetic group of conditions such as autism.
Introduction
There is continuing debate over what defines autism at the various levels of comparison.
While specificity of data improves as one approaches the molecular level, it is now very apparent that at the genetic level of comparison autism is highly heterogeneous [1, 2] . We have therefore proposed that the "Least Common Denominator" of autism lies in the next level beyond, within the neuroanatomy of the conditions [3] . An increase in number of neocortical minicolumns seems to be a common underlying element to a significant number of cases, a phenotype which complements many fMRI studies which have reported differences in coordinated processing in autism during various cognitive tasks ( [4] for review). It also complements well the molecular work thus far performed and which will be reviewed here in subsequent sections. As Casanova et al. [5] have proposed, the increase in minicolumnar number in autism may be due to a rise in germinal cell numbers within the paraventricular area underlying the developing neocortex, which may predispose towards a particular phenotype of neuronal connectivity, one which preferences short-range arcuate fibers over longer-range white matter tracts. An increase in neural stem cells will subsequently lead to an increase in neocortical tissue, i.e., because cortical tissue adheres to a general radial configuration, more minicolumns will be generated provided there are no considerable aberrations in processes such as migration or differentiation (for example, see [6] ). In addition, increased neuronal cell numbers and density have been noted in other areas of the telencephalon in autism aside from neocortex, including the hippocampus, the amygdala, and other portions of the limbic system ( [7] , for review). Ultimately, the overall number of minicolumns within a local tissue may impact neuropil width, brainwide connectivity patterns, and local patterns of neuritogenesis, synaptogenesis, and plasticity [5, [8] [9] [10] [11] .
Autism as a larger group is heterogenetic and while this group of conditions is highly heritable, they are not strictly "inherited", as evidenced by the discordance even amongst some monozygotic twins [12] . The monozygote concordance rates in the idiopathic conditions range from approximately 60%-92%
depending upon behavioral measurements used, and therefore even at measures most lenient concordance falls shy of 100% ( [13] for review). Thus, environmental factors, as with many such developmental conditions, are suggested to play their role in autism [14] . Whether these factors act as though flipping a genetic on/off switch or they simply exacerbate an already present condition is still to be determined, although the presence of a broader autism phenotype existing amongst family of the affected may help to answer this question in future.
In early infancy, autistic babies usually present with average cranial size, in contrast to the larger cranial sizes seen in early childhood [15] . Many studies have therefore focused their efforts on investigating postnatal development during the time when head circumference in the conditions seems to increase so dramatically. In addition, cases of autism in which regression occurs during this time period has lead investigators to focus on development of the first two years of life [16] . [20, 21] . However, while autism is illustrative of some of the extreme localized intelligences humanity can achieve, it also shows us that bigger is not always better. [47] . While FMRP mutation has been highly associated with regulation of synapse formation, more recent work has broadened our awareness of the scope of its functions to include that of progenitor proliferation and neurogenesis [48, 49] . portion of E-cadherin [29] . Anchoring of the cytoskeleton in turn inhibits the "treadmilling" of that filament, stabilizing it [52] . Through formation of the cadherin/β-catenin/α-catenin/vinculin complex, p120 is recruited to E-cadherin, linking the adherens junction to several intracellular signaling pathways such as various receptor tyrosine kinases (RTK) [53] . effectors come together to coordinate cellular development, β-catenin occupies a key position in which it helps to maintain homeostasis at the adherens junction and at the nascent synapse, yet also becomes a transcription factor once freed into the cytosol, acting as a messenger from membrane to nucleus.
targeting β-catenin in progenitor proliferation
A number of genetic and teratogenic animal models have been used to study the autism phenotypes. As mentioned, PTEN, TSC1/2, and [64, 65, 66] . In 1994, however, increased autism risk was added to the list of developmental disruptions following in utero exposure [66] . A later study by Moore et al. [67] confirmed VPA as a significant risk factor for autism, finding that approximately Ovarian Syndrome (PCOS) [88] . In part, this may be due to the hyperandrogenism and hyperinsulinemia common to both conditions. Along these lines, Ingudomnukul et al. [89] found that high-functioning autistic females and their mothers were more likely than controls to present with testosterone-related disorders, including that of PCOS. These studies together support a link of high androgen levels to autistic symptomotology.
PCOS, as a heterogeneous condition, frequently presents with obesity, hyperinsulinemia, hyperandrogenism, poor progesterone sensitivity, abnormal patterns of leutenizing hormone (LH) activity, and extended periods of anovulation with high levels of estrogen [90] . While androgens at the molecular level tend to promote entry of β-catenin into the nucleus [91, 92] , there is evidence to suggest that activation of the androgen receptor within the neocortex and hippocampus is in fact antagonistic to Wnttargeted gene transcription [93] . Therefore, Estrogen is vitally important in sexual differentiation of the mammalian brain, with higher levels leading to greater masculinization [94] . While prenatal and neonatal androgen levels may be high in autism, it is estrogen which is largely responsible for exacerbation of the sexually dimorphic development of the neocortex and hippocampus [94] . Neural stem cells in these areas exhibit high levels of both aromatase and the estrogen receptor, ERβ, throughout neurogenesis, and ERα during late neurogenesis [95] , suggesting that excess androgens may be aromatized into estrogen and used to promote male-pattern growth reasons still unknown [108, 110] . However, the immune system may act more directly upon the central nervous system in reaction to infection.
Following the rubella epidemics which hit the
United States in the 1960s, it became apparent that prenatal rubella conferred a considerably higher risk for developing autism. Chess et al. [114] found that of those children diagnosed This review has thus far focused on teratogenic agents which have received considerable attention in the literature. And, while we still struggle to understand their complexities, we are gaining ground rapidly. However, we would also like to present the reader with a potential teratogen which has been little studied and, for the most part, assumed safe. While various epidemiological and animal studies have been performed to date investigating the safety of prenatal ultrasound, we would like to present an alternate view of the method which will hopefully lead the reader to the conclusion that further research elucidating its bioeffects and stricter regulations of its application are imperative.
Prenatal ultrasound use has grown in popularity since the 1970s, with some mothers receiving four or more ultrasounds in a single pregnancy. This explosive use, however, does not necessarily reflect the occurrence rate of at-risk pregnancies, and in fact one study by
You et al. [120] found that increased use was even more pronounced in those at low-risk.
Ultrasound practice has changed within the last several decades as well. In heavier patients with greater amounts of adipose tissue, a higher intensity level is necessary in order to attain adequate image resolution; therefore, regulations were loosened in the 1990s in order to accommodate a greater range of patients [121] . Unfortunately, practitioners, nurses, and technicians tend to have a poor understanding of the thermal and cavitational risks which accompany ultrasound use, and so the safety of the patient is dependent upon the ultrasound "smart machine" to gauge exposure levels and shut down when dangerous levels have been reached [122] .
In 2010, we proposed a link to the rising diagnostic rates of autism, increasing ultrasound use, and its poor regulation [123] . In lieu of osteoblasts [128] . And it also has similar growth effects on chondrocytes, activating the PI3K/ Akt pathway [129] . Aside from its use in tissue regeneration, ultrasound has been utilized for transdermal delivery of medication due to its capacity for increasing cellular permeability; it therefore has been used with topical drugs which are normally limited by their molecular weights [130, 131] . Ultrasound also has predictable effects on the endothelium:
because the shear stress created by ultrasonic pulses is interpreted by the endothelium as an increase in blood pressure, dilation of the vasculature occurs [132] . This effect has been used to the particular benefit of cardiovascular imaging studies, for instance not only allowing surgeons to view signs of coronary artery disease but also to guide the placement of arterial stents with greater accuracy [133, 134] .
The endothelium also responds to shear stress, such as ultrasound interpreted as blood pressure, via proliferation of endothelial progenitors and mature endothelial cells and elongation into the direction of the flow [135] .
Accompanying growth following ultrasound exposure, the endothelium produces molecules such as nitric oxide (NO), prostaglandin E2, interleukin-8 (IL-8), basic fibroblast growth factor (bFGF or FGF2), and vascular endothelial growth factor (VEGF) [136, 137] . In particular, FGF2 and VEGF are shared by both the endothelium and neural stem cell populations [138] . expression levels of these adhesion molecules [156] .
As mentioned prior, while FMRP regulates progenitor and neural proliferation, it also appears to act as a translational suppressor within synapses [48] . 
discussion
We have attempted to cover a considerable breadth of material within this review.
And even though that breadth may seem overwhelming at first, we hope the reader may appreciate that the etiology of autism probably lies in very fundamental processes of central nervous system development.
Only processes so fundamental could link such genetic heterogeneity to a common behavioral phenotype. Ultimately, we believe it is the nature of connectivity which defines the autistic syndromes. While overproliferation of the neural stem cell population may also commonly be targeted and may lead to subtler variations in behavioral phenotype, directly targeting neuritic and synaptic growth may be a "shortcut" to the conditions as well, although further research is still needed to determine whether this is the case.
In support of our proposal, recent work published by the Autism Genome Project
Consortium [163] has found that in comparing 996 autistic individuals of European descent to 1,287 matched controls, copy number variations were found consistently across three functional domains: 1) cellular proliferation,
2) cell projection and motility (e.g., neurite growth and synaptogenesis), and 3) GTPase/ Ras signaling. While GTPase/Ras signaling is heavily involved in the former two processes and, therefore, may potentially be subsumed under either category, proliferation and projection are distinct enough to suggest that whatever common ground these domains do share, either molecularly or functionally, it is that which may underlie the development of autism [164, 165] .
We have also presented a number of teratogenic agencies which may mimic or exacerbate effects as those seen in the singlegene syndromes and genetic animal models.
Hopefully, these examples of teratogenicity we may no longer be subjected to comparable levels as we have been in the past, potentially tilting a longheld balance between genetics and molecular epigenetics. As also may be found with ultrasound, through its unwise use we are potentially altering the molecular environment in which our children are developing prenatally. 
